1. Halaas JL, Gajiwala KS, Mafei M, Cohen SL, Chait BT, Rabinowitz D, etal . Weight reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543–6. 2. Perez Fontan M, Rodriguez–Carmona A, Cordido F, Garcia–Buela J. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis and hemodialysis. A comparative analysis. AmJ Kidney Dis 1999; 34:824–31. 3. Mistry CD, O’Donoghue DJ, Nelson S, Gokal R, Ballardie FW. Kinetic and clinical studies of beta 2-microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearance using glucose polymer. Nephrol Dial Transplant 1990; 5:513–19. 4. Imholz ALT, Brown CB, Koomen GCM, Arisz L, Krediet RT. The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993; 9:25–30. 5. Ho-dac-Pannekeet MM, Schouten A, Langendijk MJ, Hiralall JK, deW aart DR, Struijk DG, etal . Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50:979–86. 6. Kagan A, Haran N, Leschinsky L, Shuali N, Rapoport J. Leptin in CAPD patients: serum concentrations and peritoneal loss. Nephrol Dial Transplant 1999; 14: 400–5. 7. Landt M, Parvin CA, Dagogo-Jack S, Bryant B, Coyne DW. Leptin elimination in hyperleptinemic peritoneal dialysis patients. Nephrol Dial Transplant 1999; 14: 732–7. 8. Arkouche W, Juillard L, Delawari E, Lasne Y, Combarnous F, Galland RS, etal . Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis. AmJ Kidney Dis 1999; 34:839–44. 9. Opatrná S, OpatrnΩ KJr , Senft V, Stehlík F, Racek J. The effect of icodextrin-based dialysis solution on selected metabolic parameters in CAPD patients [Abstract]. Perit Dial Int 2001; 21(Suppl 2):S98. 10. Heimbürger O, Wang T, Lönnqvist F, Stenvinkel P. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. Nephrol Dial Transplant 1999; 14:723–7. 11. Waniewski J, Wang T, Heimbürger O, Werynski A, Lindholm B. Discriminative impact of ultrafiltration on peritoneal protein transport. Perit Dial Int 2000; 20:39–46. 12. Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43:1339–46. 13. Rippe B, Stelin G. Simulation of peritoneal solute transport during CAPD. Application of two-pore formalism. Kidney Int 1989; 35:1234–44. 14. Krediet RT, Ho-dac-Pannekeet MM, Imholz ALT, Struijk DG. Icodextrin’s effects on peritoneal transport. Perit Dial Int 1997; 17:35–41. 15. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996; 45:984–7.
[1]
A. Watson,et al.
Guidelines by an AD HOC European Committee for Elective Chronic Peritoneal Dialysis in Pediatric Patients
,
2001,
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[2]
P. Whitten,et al.
Systematic review of studies of patient satisfaction with telemedicine
,
2000,
BMJ : British Medical Journal.
[3]
A. Watson,et al.
Gastrostomy buttons for nutritional support on chronic dialysis.
,
1998,
Nephrology, Dialysis and Transplantation.
[4]
A. Allen,et al.
Telemedicine technology and clinical applications.
,
1995,
JAMA.
[5]
K A Stroetmann,et al.
Improving quality of life for dialysis patients through telecare
,
2000,
Journal of telemedicine and telecare.
[6]
A. Watson,et al.
Avoiding and Coping with Patient and Family Burn out
,
1998
.
[7]
A. Watson.
Stress and burden of care in families with children commencing renal replacement therapy.
,
1997,
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[8]
B. Piraino,et al.
Compliance in CAPD and CCPD patients as measured by supply inventories during home visits.
,
1998,
American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9]
Steven L. Cohen,et al.
Weight-reducing effects of the plasma protein encoded by the obese gene.
,
1995,
Science.